Trials / Unknown
UnknownNCT04191629
Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema
Phase 1 Clinical Study to Evaluate Safety and Tolerability of Magnetic Human Corneal Endothelial Cells in the Treatment of Corneal Edema
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Valeria Sanchez-Huerta · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Single center, phase 1 study to evaluate the safety and tolerability of EO1404 in subjects with corneal edema secondary to pseudophakic bullous keratopathy or Fuch's endothelial dystrophy.
Conditions
- Corneal Edema
- Fuchs Dystrophy
- Fuchs' Endothelial Dystrophy
- Pseudophakic Bullous Keratopathy
- Corneal Endothelial Dystrophy
- Corneal Transplant Failure
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | EO1404 | |
| PROCEDURE | Endothelial brushing or Descemet stripping |
Timeline
- Start date
- 2016-05-04
- Primary completion
- 2020-12-31
- Completion
- 2021-02-28
- First posted
- 2019-12-10
- Last updated
- 2019-12-10
Locations
1 site across 1 country: Mexico
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04191629. Inclusion in this directory is not an endorsement.